proteinas
sever
acut
respiratori
syndrom
sar
coronaviru
demonstr
key
target
drug
design
sar
interact
sar
coronaviru
proteinas
octapeptid
interfac
inhibitor
studi
affin
capillari
electrophoresi
ace
bind
constant
estim
chang
migrat
time
analyt
buffer
solut
contain
differ
concentr
sar
proteinas
result
show
sar
proteinas
abl
complex
octapeptid
competit
bind
constant
addit
thermodynam
paramet
deduc
reveal
hydrophob
interact
might
play
major
role
along
electrostat
forc
bind
process
ace
method
use
could
develop
effect
simpl
way
appli
largescal
drug
screen
evalu
late
sever
acut
respiratori
syndrom
sar
infect
peopl
mostli
china
hong
kong
taiwan
canada
caus
death
due
infect
novel
human
coronaviru
sequenc
complet
genom
novel
human
coronaviru
sarsassoci
coronaviru
sarscov
determin
contain
nucleotid
length
open
read
frame
genom
organ
similar
known
coronavirus
includ
two
human
coronavirus
phylogenet
analysi
sequenc
comparison
indic
sarscov
close
relat
three
previous
known
group
character
coronavirus
sarscov
main
proteinas
kda
also
call
proteinas
essenti
life
cycl
sarscov
play
pivot
role
mediat
viral
replic
transcript
function
extens
proteolyt
process
two
replicas
polyprotein
kda
kda
control
activ
coronaviru
replic
complex
avail
numer
inhibitor
coronaviru
proteinas
effici
express
proteinas
prefer
target
task
discov
drug
sar
group
determin
crystal
structur
human
coronaviru
strain
main
proteinas
substrat
analogu
hexapeptidyl
chloromethyl
keton
cmk
inhibitor
complex
porcin
coronaviru
transmiss
gastroenter
viru
tgev
main
proteinas
result
reveal
remark
degre
conserv
substratebind
site
homolog
model
sarscov
main
proteinas
construct
crystal
structur
sarscov
main
proteinas
differ
ph
valu
bind
specif
inhibitor
covalentbond
substrat
analogu
report
group
provid
insight
substrat
bind
site
structur
basi
ration
drug
design
virtual
screen
test
xiong
et
al
indic
avail
proteinas
inhibitor
mddr
databas
might
dock
bind
pocket
tgev
main
proteinas
sarscov
proteinas
seri
cellbas
assay
sar
viru
vero
cell
includ
enzymelink
immunosorb
assay
elisa
western
blot
analysi
immunofluoresc
flow
cytometri
assay
appli
report
wu
et
al
screen
exist
drug
natur
product
synthet
compound
identifi
effect
antisar
agent
result
show
approxim
compound
activ
lm
compound
activ
lm
base
atom
coordin
sarscov
main
proteinas
research
conduct
group
deriv
avlqsgfr
octapeptid
enzym
interact
activ
site
sar
enzym
six
hydrogen
bond
clear
definit
bind
pocket
kuo
et
al
prepar
peptid
fluoresc
quench
pair
dabcyl
edan
end
peptid
substrat
use
fluorogen
peptid
substrat
character
sar
main
proteinas
screen
inhibitor
capillari
electrophoresi
ce
may
offer
sever
advantag
studi
interact
small
ligand
biomacromolecul
includ
small
sampl
consumpt
nanogram
short
analysi
time
eas
autom
high
effici
high
resolv
power
one
compani
cetek
develop
optim
ce
assay
advanc
ce
assay
high
inform
bind
weak
bind
k
b
macromolecul
small
ligand
detect
easili
affin
capillari
electrophoresi
ace
anoth
advantag
ace
method
interact
compon
studi
solut
therebi
elimin
possibl
denatur
conform
alter
biomacromolecul
protein
nucleic
acid
variou
affin
interact
drugprotein
proteinprotein
proteinnucl
acid
proteincarbohydr
peptideantibiot
enzymecofactor
lectinsugar
antigenantibodi
cyclodextrin
cd
enantiom
investig
ace
recent
year
demonstr
previous
dimer
sar
proteinas
biolog
function
form
play
major
role
catalysi
inhibitor
target
dimer
interfac
new
strategi
control
activ
sar
proteinas
one
monom
sar
proteinas
bind
specif
ntermin
interfac
compet
dimer
interact
proteinas
octapeptid
interfac
inhibitor
design
accord
amino
acid
sequenc
n
terminu
sar
proteinas
current
studi
simpl
effect
ce
method
low
sampl
consumpt
develop
appli
studi
interact
sar
proteinas
octapeptid
interfac
inhibitor
bind
constant
measur
chang
migrat
time
octapeptid
inhibitor
differ
concentr
sar
proteinas
run
buffer
solut
octapeptid
found
bind
sar
proteinas
specif
competit
thermodynam
analysi
indic
hydrophob
interact
play
major
role
along
electrostat
forc
bind
process
sar
proteinas
express
escherichia
coli
purifi
accord
publish
procedur
octapeptid
serglyphearglysmetalaph
synthes
solidphas
peptid
synthesi
use
standard
strategi
purifi
reversephas
hplc
bovin
serum
albumin
bsa
mw
ovalbumin
ova
mw
purchas
fluka
reagent
analyt
grade
without
purif
deioniz
water
use
throughout
apparatu
ce
perform
beckman
pace
system
fullerton
ca
usa
uncoat
fuse
silica
capillari
beckman
cm
lm
id
cm
detector
use
capillari
chamber
temperatur
control
forc
liquid
cool
run
voltag
kv
normal
polar
mode
appli
uv
detect
perform
nm
multipurpos
refriger
centrifug
beckman
appli
clear
trap
air
bubbl
run
buffer
solut
contain
sar
proteinas
use
concentr
sar
proteinas
stock
solut
determin
uv
absorb
nm
concentrationmg
ml
stock
solut
octapeptid
bsa
ova
prepar
accur
weigh
defin
amount
compound
dissolv
defin
volum
deioniz
water
store
run
buffer
ce
experi
mm
sodium
phosphat
ph
investig
octapeptid
sar
proteinas
solut
mm
sodium
phosphat
buffer
ph
prepar
dilut
defin
volum
stock
solut
constant
volum
buffer
solut
constant
concentr
octapeptid
sampl
dimethyl
sulfoxid
dmso
serv
electroosmot
flow
eof
marker
ad
sampl
concentr
vv
prove
influenc
sar
proteinas
concentr
less
vv
vari
concentr
sar
proteinas
run
buffer
prepar
lm
solut
deioniz
water
store
filter
cellulos
acet
membran
filter
shanghai
xingya
resin
shanghai
china
sonic
min
remov
air
solut
prior
use
sar
proteinas
solut
centrifug
min
rpm
exclud
air
solut
use
new
capillari
condit
min
naoh
min
water
min
run
buffer
measur
capillari
flush
min
naoh
min
water
min
run
buffer
sampl
contain
octapeptid
dmso
introduc
capillari
highpressur
inject
psi
electrophoresi
carri
use
phosphat
buffer
solut
contain
differ
concentr
sar
proteinas
lm
separ
triplic
rel
standard
deviat
rsd
migrat
time
calcul
seri
three
experi
carri
sampl
within
day
bind
constant
k
b
fundament
import
paramet
biolog
activ
molecul
principl
method
determin
bind
constant
exploit
chang
migrat
time
complex
sampl
background
electrolyt
contain
complex
agent
ad
sar
proteinas
background
solut
bg
octapeptid
inhibitor
interact
proteinas
equilibrium
repres
follow
equat
assum
complex
form
op
octapeptid
sar
proteinas
complex
respect
k
b
bind
constant
eq
point
yang
et
al
capac
factor
k
use
indic
describ
relationship
retent
time
mass
distribut
equilibrium
chromatographi
use
describ
migrat
behavior
activ
compound
ce
moreov
addit
sar
proteinas
bg
appli
pseudostationari
phase
base
previou
work
bind
constant
measur
accord
follow
equat
phase
ratio
op
concentr
octapeptid
stationari
phase
op
initi
concentr
octapeptid
without
addit
sar
proteinas
mobil
phase
defin
chromatographi
capac
factor
k
equal
migrat
time
sampl
neutral
marker
respect
linear
relationship
k
versu
concentr
sar
proteinas
bind
constant
calcul
slope
intercept
b
weak
interact
sever
antihiv
compound
hiv
transactivationrespons
tar
rna
bsa
success
studi
simultan
quickli
use
method
bind
constant
evalu
pharmacolog
activ
inhibitor
bind
sar
proteinas
physiolog
system
simul
physiolog
system
phosphat
buffer
system
mm
ph
use
bind
studi
migrat
time
octapeptid
dmso
measur
seven
run
buffer
solut
contain
differ
concentr
sar
proteinas
lm
experiment
data
rsd
valu
summar
tabl
reproduc
migrat
time
well
base
valu
rsd
less
set
electropherogram
migrat
time
shift
octapeptid
inhibitor
versu
sar
proteinas
concentr
chang
shown
fig
plot
k
versu
concentr
sar
proteinas
two
temperatur
base
tabl
data
shown
fig
bind
constant
inhibitor
proteinas
determin
four
time
two
temperatur
calcul
accord
eq
averag
valu
rsd
n
rsd
n
rsd
valu
larger
due
instabl
higher
capillari
temperatur
demonstr
previous
dimer
sar
proteinas
biolog
function
form
play
major
role
catalysi
addit
one
monom
sar
proteinas
bind
one
specif
ntermin
interfac
compet
dimer
interact
proteinas
octapeptid
inhibitor
design
accord
amino
acid
sequenc
n
terminu
sar
proteinas
concentr
sar
proteinas
less
mg
ml
current
experiment
condit
main
form
proteinas
thought
monom
bind
constant
octapeptid
sar
proteinas
measur
dissoci
constant
dimer
proteinas
estim
lm
thu
octapeptid
inhibitor
bind
monom
proteinas
competit
prevent
dimer
effect
moreov
interact
octapeptid
two
common
protein
bsa
ova
studi
neg
control
condit
avoid
influenc
nonspecif
absorpt
compar
fig
plot
bsa
similar
fig
bind
constant
calcul
wherea
plot
ova
random
fig
result
show
octapeptid
could
interact
bsa
weakli
could
bind
ova
specif
bind
octapeptid
inhibitor
sar
proteinas
small
molecul
bind
macromolecul
four
type
interact
hbond
van
der
waal
electrostat
hydrophob
interact
thermodynam
paramet
enthalpi
chang
dh
entropi
chang
ds
bind
process
import
confirm
bind
mode
dh
vari
significantli
temperatur
rang
studi
enthalp
contribut
gibb
free
energi
dg
determin
accord
follow
equat
k
k
bind
constant
temperatur
respect
r
ga
constant
j
mol
k
free
energi
chang
estim
follow
relationship
k
bind
constant
correspond
temperatur
entropi
chang
determin
follow
equat
base
valu
bind
constant
thermodynam
paramet
dh
dg
ds
measur
accord
eq
respect
valu
summar
tabl
shown
tabl
dh
valu
neg
experiment
condit
demonstr
bind
reaction
exotherm
process
sign
magnitud
thermodynam
paramet
associ
variou
kind
interact
character
point
view
water
structur
posit
entropi
frequent
taken
evid
hydrophob
interact
also
shown
posit
entropi
slightli
neg
enthalpi
might
manifest
electrostat
interact
ionic
speci
aqueou
solut
base
experiment
data
conclud
hydrophob
interact
may
play
major
role
wherea
electrostat
forc
also
contribut
bind
process
sar
proteinas
octapeptid
inhibitor
consist
previou
work
sar
therapi
requir
develop
antivir
compound
effect
prevent
treat
diseas
simpl
reliabl
ce
method
low
sampl
consumpt
appli
studi
interact
sar
proteinas
octapeptid
interfac
inhibitor
bind
constant
determin
chang
migrat
time
octapeptid
inhibitor
differ
concentr
sar
proteinas
run
buffer
octapeptid
shown
bind
sar
proteinas
competit
bind
constant
k
b
valu
analysi
thermodynam
paramet
enthalpi
chang
dh
entropi
chang
ds
indic
hydrophob
interact
might
play
major
role
along
electrostat
forc
bind
process
ace
method
wide
applic
largescal
ligand
screen
protein
target
